Greeniuronic

Beyond standard HA: the high-absorption botanical solution for advanced joint care

In the competitive nutraceutical landscape, GreenIuronic® establishes a new benchmark for therapeutic efficacy, substantiated by pioneering research. Utilizing a dual-model approach, combining a simulated osteoarthritic joint environment with an EFSA-validated 3D human intestinal organoid system, scientists have demonstrated the superior performance of this botanical powerhouse over conventional fermented sodium hyaluronate. The study confirms that GreenIuronic® delivers a multi-dimensional advantage for joint health:

  • Superior bioavailability: Validated intestinal modeling shows significantly higher absorption through the epithelial lining, ensuring that active compounds effectively reach systemic circulation
  • Targeted chondrocyte support: Unlike standard HA, GreenIuronic® is strongly assimilated by chondrocytes, the primary cells responsible for cartilage synthesis and extracellular matrix repair
  • Systemic anti-inflammatory potency: By outperforming traditional HA in reducing inflammatory markers, GreenIuronic® addresses the root cause of joint stiffness and discomfort, rather than just the symptoms
  • Enhanced cellular homeostasis: The ingredient promotes long-term joint health by stabilizing cellular function and shielding the joint environment from oxidative and mechanical stress

For manufacturers, GreenIuronic® represents a strategic opportunity to transition from generic supplementation to a science-backed, high-absorption solution designed to help managing osteoarthritic conditions and restore joint mobility at the cellular level.